Just saw story on the 6 o.clock news. Healthlinx have confirmed screening accuracy of ovarian cancer test and should be on the market later in the year. Could be worth a look.
HTX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
